Glutamine and Belsomra drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Glutamine (glutamine) and Belsomra (suvorexant). Common drug interactions include nausea among females and benign prostatic hyperplasia among males.

The phase IV clinical study analyzes what interactions people have when they take Glutamine and Belsomra. It is created by eHealthMe based on reports of 20 people who take the same drugs from the FDA, and is updated regularly.

What is Glutamine?

Glutamine has active ingredients of glutamine. It is often used in muscle building therapy. eHealthMe is studying from 2,705 Glutamine users. Check the latest studies of Glutamine.

What is Belsomra?

Belsomra has active ingredients of suvorexant. It is often used in insomnia. eHealthMe is studying from 12,961 Belsomra users. Check the latest studies of Belsomra.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

20 people who take Glutamine and Belsomra together, and have interactions are studied.

Glutamine and Belsomra drug interactions.

What are the common drug interactions of Glutamine and Belsomra, by gender? *:

female:

Nausea (feeling of having an urge to vomit)
Cardiac failure
Depression
Disease progression
Electrocardiogram qt prolonged
Hepatic failure (liver failure)
Hypoaesthesia oral (reduced sense of touch or sensation in mouth)
Malaise (a feeling of general discomfort or uneasiness)
Neuropathy peripheral (surface nerve damage)
Respiratory disorder (respiratory disease)

male:

Benign prostatic hyperplasia (benign enlargement of the prostate)
Blood pressure fluctuation
Pulmonary toxicity (side effects on the lungs)
Supraventricular tachycardia (rapid heart rhythm originating at or above the atrioventricular node)
Infection
Malignant neoplasm progression (cancer tumour came back)
Pneumonia
Prerenal failure
Rash
Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down)

What are the common drug interactions of Glutamine and Belsomra, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Cardiac failure
Disease progression
Hepatic failure (liver failure)
Respiratory disorder (respiratory disease)
Dyspnoea (difficult or laboured respiration)
Hyperhidrosis (abnormally increased sweating)
Nausea (feeling of having an urge to vomit)
Neutropenia (an abnormally low number of neutrophils)
Palpitations (feelings or sensations that your heart is pounding or racing)
Vomiting

50-59:

Nightmare (unpleasant dream)

60+:

Delirium (wild excitement)
Nausea (feeling of having an urge to vomit)
Infection
Malaise (a feeling of general discomfort or uneasiness)
Malignant neoplasm progression (cancer tumour came back)
Neuropathy peripheral (surface nerve damage)
Pneumonia
Prerenal failure
Rash
Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down)

What are the existing conditions these people have? *

Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 6 people, 30.00%
Cancer Pain: 4 people, 20.00%
Vulvitis (inflammation of the vulva): 2 people, 10.00%
Neuropathy Peripheral (surface nerve damage): 2 people, 10.00%
Ascites (accumulation of fluid in the abdominal cavity): 2 people, 10.00%
Constipation: 2 people, 10.00%
Hepatic Function Abnormal: 2 people, 10.00%
Hypopharyngeal Cancer: 2 people, 10.00%
Lung Cancer - Non-Small Cell (lung cancer): 2 people, 10.00%
Metastases To Bone (cancer spreads to bone): 2 people, 10.00%

* Approximation only. Some reports may have incomplete information.

Do you take Glutamine and Belsomra?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously